Literature DB >> 7218733

Measurement of chemiluminescence in freshly drawn human blood. I. Role of granulocytes, platelets, and plasma factors in zymosan-induced chemiluminescence.

T Kato, H Wokalek, E Schöpf, H Eggert, M Ernst, E T Rietschel, H Fischer.   

Abstract

The present investigations were undertaken to find out whether chemiluminescence measurements of stimulated granulocytes can be carried out in freshly drawn blood and -- because of the ease of the method -- be introduced into routine diagnostics. Blood was drawn from the cubital vein of healthy volunteers at various times and under various conditions. Subsequently the zymosan induced and luminol amplified chemiluminescence was recorded and analyzed. It could be demonstrated that variations existed between individuals which can, however, be minimized when photon counts obtained under standard conditions were related to the number of granulocytes present in the blood samples. It could be further demonstrated that also platelets are activated by zymosan as well an that they, contribute to the total chemiluminescence by a share of about 5%. Platelet chemiluminescence can effectively be suppressed by aspirin. Opsonising factors in plasma (presumably antibodies and/or complement) play a decisive role in the intensity and kinetics of blood chemiluminescence. Measurements of zymosan induced chemiluminescence in freshly drawn unfractionated and fractionated blood seem to be especially suited to monitor and analyze deviations and defects of the cellular and humoral defence mechanisms.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7218733     DOI: 10.1007/bf01476577

Source DB:  PubMed          Journal:  Klin Wochenschr        ISSN: 0023-2173


  36 in total

1.  Polymorphonuclear leukocytes in antibody-dependent cellular cytotoxicity.

Authors:  R P Gale; J Zighelboim
Journal:  J Immunol       Date:  1975-03       Impact factor: 5.422

2.  An experimental investigation of the rôle of the blood fluids in connection with phagocytosis. 1903.

Authors:  A E Wright; S R Douglas; J B Sanderson
Journal:  Rev Infect Dis       Date:  1989 Sep-Oct

3.  Platelet function in C6-deficient rabbits. Aggregation and secretion induced by collagen and zymosan.

Authors:  F A Christian; J L Gordon
Journal:  Immunology       Date:  1975-07       Impact factor: 7.397

4.  Defective initiation of oxidative metabolism in polymorphonuclear leukocytes.

Authors:  L Harvath; B R Andersen
Journal:  N Engl J Med       Date:  1979-05-17       Impact factor: 91.245

5.  Biological defense mechanisms. The production by leukocytes of superoxide, a potential bactericidal agent.

Authors:  B M Babior; R S Kipnes; J T Curnutte
Journal:  J Clin Invest       Date:  1973-03       Impact factor: 14.808

6.  Effect of variation of the interval between venepuncture and measurement of platelet adhesiveness by the Payling Wright method.

Authors:  T Fyfe; E Hamilton
Journal:  Lancet       Date:  1967-09-09       Impact factor: 79.321

7.  Acetylation of the NH2-terminal serine of prostaglandin synthetase by aspirin.

Authors:  G J Roth; C J Siok
Journal:  J Biol Chem       Date:  1978-06-10       Impact factor: 5.157

8.  Leukocyte-platelet interactions in a murine model of Chediak-Higashi syndrome.

Authors:  S S Kaplan; S S Boggs; M A Nardi; R E Basford; J M Holland
Journal:  Blood       Date:  1978-10       Impact factor: 22.113

9.  Biological defense mechanisms. The effect of bacteria and serum on superoxide production by granulocytes.

Authors:  J T Curnutte; B M Babior
Journal:  J Clin Invest       Date:  1974-06       Impact factor: 14.808

10.  Platelet phagocytosis and aggregation.

Authors:  H Z Movat; W J Weiser; M F Glynn; J F Mustard
Journal:  J Cell Biol       Date:  1965-12       Impact factor: 10.539

View more
  27 in total

1.  Polymorphonuclear leukocyte chemiluminescence induced by formylmethionyl-leucyl-phenylalanine and phorbol myristate acetate: effects of catalase and superoxide dismutase.

Authors:  C Dahlgren
Journal:  Agents Actions       Date:  1987-06

2.  Ber-MAC3: new monoclonal antibody that defines human monocyte/macrophage differentiation antigen.

Authors:  E Backé; R Schwarting; J Gerdes; M Ernst; H Stein
Journal:  J Clin Pathol       Date:  1991-11       Impact factor: 3.411

3.  Interaction between human neutrophils and corneocytes: corneocyte-induced respiratory burst of neutrophils assessed by chemiluminescence.

Authors:  T Kato; M Hara; O Iizawa; T Terui; H Tagami
Journal:  Inflammation       Date:  1991-06       Impact factor: 4.092

4.  Neutrophil metabolic dysfunction in genetically heterogeneous patients with glycogen storage disease type 1b.

Authors:  K Narisawa; S Ishizawa; H Okumura; K Tada; T Kuzuya
Journal:  J Inherit Metab Dis       Date:  1986       Impact factor: 4.982

5.  Lucigenin-dependent chemiluminescence in neutrophils stimulated with stratum corneum sheet.

Authors:  T Kato; O Iizawa; T Terui; H Tagami
Journal:  Arch Dermatol Res       Date:  1990       Impact factor: 3.017

6.  Effects of psoriatic scale extracts on oxidative metabolic responses in granulocytes assessed by chemiluminescence.

Authors:  T Kato; T Terui; H Takematsu; H Tagami
Journal:  Inflammation       Date:  1989-02       Impact factor: 4.092

7.  Monocyte/macrophage-reactive monoclonal antibody Ki-M6 recognizes an intracytoplasmic antigen.

Authors:  M R Parwaresch; H J Radzun; H Kreipe; M L Hansmann; J Barth
Journal:  Am J Pathol       Date:  1986-10       Impact factor: 4.307

8.  Intra- and extracellular events in luminol-dependent chemiluminescence of polymorphonuclear leukocytes.

Authors:  G Briheim; O Stendahl; C Dahlgren
Journal:  Infect Immun       Date:  1984-07       Impact factor: 3.441

9.  Brief myocardial ischemia affects free radical generating and scavenging systems in dogs.

Authors:  S Hoshida; T Kuzuya; N Yamashita; H Oe; H Fuji; M Hori; M Tada; T Kamada
Journal:  Heart Vessels       Date:  1993       Impact factor: 2.037

10.  Role of myeloperoxidase in luminol-dependent chemiluminescence of polymorphonuclear leukocytes.

Authors:  C Dahlgren; O Stendahl
Journal:  Infect Immun       Date:  1983-02       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.